HB2456 would require Medicaid and Medicare Part D coverage for GLP1 drugs approved for weight loss in Hawaii.

HB2456 addresses the exclusion of GLP1 drugs from Medicaid and Medicare Part D coverage in Hawaii for weight loss purposes. The bill mandates the Department of Human Services to cover these drugs, which have been approved by the FDA for weight loss, for Medicaid and Medicare Part D recipients. The coverage is contingent on the drug being FDA-approved for weight loss, prescribed by a practitioner, and without requiring prior authorization. The bill aims to address obesity, a significant health issue linked to various conditions, by making these drugs more accessible.

HB2456 would require Medicaid and Medicare Part D coverage for GLP1 drugs approved for weight loss in Hawaii.

HB2456 addresses the exclusion of GLP1 drugs from Medicaid and Medicare Part D coverage in Hawaii for weight loss purposes. The bill mandates the Department of Human Services to cover these drugs, which have been approved by the FDA for weight loss, for Medicaid and Medicare Part D recipients. The coverage is contingent on the drug being FDA-approved for weight loss, prescribed by a practitioner, and without requiring prior authorization. The bill aims to address obesity, a significant health issue linked to various conditions, by making these drugs more accessible.